Back to top

A Phase I trial of a vaginal ring containing the ARV drug dapivirine and the contraceptive hormone levonorgestrel that found the ring was well-tolerated with no safety concerns. The study represented an important first step toward developing a product for women that could both protect against HIV and prevent unintended pregnancy.

 

First clinical trial of new dapivirine ring with both anti-HIV drug and contraceptive

finds ring is well-tolerated with no safety concerns

24-October-2018

 

See Also

MTN-030/IPM 041 Protocol

 

MTN-030/IPM 041 Study Page

 

MTN begins first trial of new dapivirine ring with both anti-HIV drug and contraceptive

03-May-2017